Your browser is no longer supported. Please, upgrade your browser.
Settings
MNKD MannKind Corporation daily Stock Chart
MNKD [NASD]
MannKind Corporation
Index- P/E4.01 EPS (ttm)1.35 Insider Own0.20% Shs Outstand119.02M Perf Week1.69%
Market Cap645.09M Forward P/E- EPS next Y-0.84 Insider Trans251.42% Shs Float80.60M Perf Month136.68%
Income128.80M PEG0.15 EPS next Q-0.22 Inst Own16.10% Short Float29.37% Perf Quarter273.79%
Sales179.90M P/S3.59 EPS this Y130.10% Inst Trans-0.15% Short Ratio3.60 Perf Half Y344.26%
Book/sh-2.22 P/B- EPS next Y11.60% ROA140.10% Target Price7.00 Perf Year115.68%
Cash/sh0.36 P/C14.86 EPS next 5Y26.80% ROE-61.20% 52W Range0.67 - 6.96 Perf YTD70.25%
Dividend- P/FCF- EPS past 5Y17.20% ROI-396.80% 52W High-22.13% Beta3.03
Dividend %- Quick Ratio0.60 Sales past 5Y411.30% Gross Margin86.80% 52W Low713.57% ATR0.67
Employees153 Current Ratio0.60 Sales Q/Q- Oper. Margin70.30% RSI (14)70.84 Volatility16.44% 17.42%
OptionableYes Debt/Eq- EPS Q/Q-7.60% Profit Margin71.60% Rel Volume1.54 Prev Close5.28
ShortableYes LT Debt/Eq- EarningsNov 06 AMC Payout0.00% Avg Volume6.58M Price5.42
Recom2.70 SMA2061.26% SMA50132.62% SMA200173.65% Volume10,118,395 Change2.65%
Oct-10-17Initiated H.C. Wainwright Buy $7
Oct-06-17Reiterated Maxim Group Buy $4 → $7
Aug-11-17Initiated Maxim Group Buy $4
May-10-16Reiterated RBC Capital Mkts Underperform $0.15 → $0.20
May-10-16Reiterated Piper Jaffray Underweight $0.05 → $0.10
Jan-06-16Reiterated RBC Capital Mkts Underperform $1 → $0.15
Jan-06-16Reiterated Piper Jaffray Underweight $1.50 → $0.05
Nov-04-15Downgrade RBC Capital Mkts Outperform → Underperform $9 → $1
Sep-09-15Downgrade Piper Jaffray Neutral → Underweight
Aug-03-15Reiterated RBC Capital Mkts Outperform $10 → $9
May-11-15Reiterated MLV & Co Hold $7 → $4
May-11-15Downgrade JP Morgan Neutral → Underweight
Apr-16-15Reiterated RBC Capital Mkts Outperform $13 → $10
Aug-12-14Reiterated RBC Capital Mkts Outperform $16 → $13
Jul-01-14Downgrade MLV & Co Buy → Hold $11
Jun-30-14Reiterated Brinson Patrick Market Outperform $12 → $15
Jun-13-14Initiated RBC Capital Mkts Outperform $16
Apr-02-14Reiterated MLV & Co Buy $9 → $11
Jun-27-13Reiterated MLV & Co Buy $6 → $8
May-15-13Initiated MLV & Co Buy $6
Oct-16-17 08:31AM  MannKind, New Labeling Approved by FDA, Recent Analysts Price Targets ACCESSWIRE
Oct-13-17 08:38AM  Options Traders Expect Huge Moves in MannKind (MNKD) Stock Zacks
Oct-12-17 09:00AM  MannKind Donates Afrezza® to Support People with Diabetes Impacted by Hurricane Maria in Puerto Rico GlobeNewswire
08:10AM  Today's Research Reports on Stocks to Watch: MannKind Corporation and Bluebird Bio ACCESSWIRE
06:18AM  Should You Buy the Dip With MannKind Stock? Motley Fool
06:04AM  7 Essential Rules for Investing in Biotech Stocks Motley Fool
Oct-11-17 05:09PM  Why Rite Aid, MannKind, and Sears Holdings Slumped Today Motley Fool -18.48%
01:14PM  Why MannKind Corporation Dropped a Day After It Ran Up Motley Fool
12:05PM  Is MannKind Corp Finally a Buy? Motley Fool
09:17AM  MannKind's stock tumbles after share offering, in wake of recent tripling in price MarketWatch
12:02AM  MannKind Announces $61 Million Registered Direct Offering of Common Stock GlobeNewswire
Oct-10-17 04:30PM  Why MannKind, Nutanix, and Smith & Nephew Jumped Today Motley Fool +25.89%
03:15PM  MannKind Tripled In The Past 3 Weeks; Vindicating Nate Pile Forbes
12:00PM  Why MannKind Corporation Stock Is Jumping Today Motley Fool
09:52AM  This top investment newsletter is winning big on one stock MarketWatch
06:49AM  [$$] MannKind Stock Seen Reaching $7 Barrons.com
Oct-07-17 10:34AM  3 Drug Stocks That Soared This Week: Are They Buys? Motley Fool
Oct-06-17 11:30PM  [$$] Charting the Market Barrons.com
09:20AM  Fridays Vital Data: MannKind Corporation (MNKD), Apple Inc. (AAPL) and Netflix, Inc. (NFLX) InvestorPlace
Oct-05-17 05:04PM  Is MannKind Corporation Stock Still a Strong Buy? Motley Fool +40.11%
02:24PM  MannKind's stock rockets on heavy volume for third-straight session MarketWatch
11:18AM  3 Tech Stocks Investors Are Watching ACCESSWIRE
Oct-04-17 06:26PM  Should You Be Tempted To Buy MannKind Corporation (MNKD) Because Of Its PE Ratio? Simply Wall St. +25.53%
04:30PM  Why MannKind, Intelsat, and Benefitfocus Jumped Today Motley Fool
01:49PM  [$$] MannKind Victorious in Label Revision Barrons.com
08:10AM  Today's Research Reports on Stocks to Watch: Mannkind and EnteroMedics ACCESSWIRE
07:00AM  Corporate News Blog - MannKind Announces Afrezza Updates from FDA; Includes New Data on Rapid Onset of Activity and Effect Duration ACCESSWIRE
Oct-03-17 08:49AM  MannKind (MNKD) in Focus: Stock Moves 7.8% Higher Zacks +20.51%
Oct-02-17 04:56PM  Why MannKind Corporation Popped Today Motley Fool +7.83%
03:02PM  Why MannKind Stock Started October With a Bang Motley Fool
09:35AM  3 Biotech Stocks That Are Trending Pre-Market On Monday ACCESSWIRE
06:00AM  FDA Updates Afrezza® Prescribing Information GlobeNewswire
Oct-01-17 05:00PM  MannKind Corporation to Hold Investor Conference Call GlobeNewswire
Sep-29-17 08:00AM  Today's Research Reports on Trending Tickers: MannKind Corporation and Spectrum Pharmaceuticals ACCESSWIRE
Sep-26-17 05:06PM  Accountant Wins My Shorting Contest Twice in a Row GuruFocus.com
07:18AM  5 Numbers That Should Get MannKind Investors Excited Motley Fool
Sep-22-17 08:50AM  Do Options Traders Know Something About MannKind (MNKD) Stock We Don't? Zacks
Sep-20-17 07:18AM  Believe It or Not, MannKind Is Now One of the Hottest Biotech Stocks on the Market Motley Fool
Sep-14-17 04:13PM  With MannKind Down Over 90%, Nvidia Enables Nate Pile To Beat The Market Forbes
Sep-13-17 08:00AM  Today's Research Reports on Trending Tickers: Cyclacel Pharmaceuticals and MannKind Corporation ACCESSWIRE
Sep-07-17 09:52AM  A Small Cap Stock Making Big Cap Waves ACCESSWIRE
09:00AM  MannKind Responds to Hurricane Harvey Devastation with Afrezza® Donation GlobeNewswire
Sep-06-17 08:00AM  MannKind, Can Internal Sales Push Improve Adoption of Afrezza? ACCESSWIRE
Sep-05-17 09:00AM  MannKind Corporation Relocates Headquarters to Westlake Village GlobeNewswire +9.09%
Sep-01-17 09:00AM  MannKind Corporation to Present at Upcoming Conferences GlobeNewswire -9.66%
Aug-30-17 03:30PM  3 Stocks Capitalizing Off Positive Market Momentum On Wednesday ACCESSWIRE +14.55%
Aug-17-17 08:10AM  Today's Research Reports on Stocks to Watch: Biogen Inc. and MannKind Corporation ACCESSWIRE
Aug-14-17 08:37AM  Options Traders Expect Huge Moves in MannKind Corporation (MNKD) Stock Zacks +5.88%
Aug-13-17 03:51AM  Edited Transcript of MNKD earnings conference call or presentation 7-Aug-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-09-17 07:00AM  Featured Company News MannKind and One Drop Announce Collaboration to Deliver a Unified Solution for Diabetes Patients ACCESSWIRE
Aug-08-17 11:55AM  MannKind Corporation (MNKD) Shares Up Despite Earnings Miss InvestorPlace
07:21AM  5 Things You'll Really Want to Know from MannKind's Q2 Update Motley Fool
Aug-07-17 07:44PM  MannKind reports 2Q loss Associated Press
04:05PM  MannKind Corporation Reports 2017 Second Quarter Financial Results GlobeNewswire
12:20PM  Investor Network: MannKind Corporation to Host Earnings Call ACCESSWIRE
09:30AM  MannKind and One Drop Partner to Launch the A-ONE Clinical Trial GlobeNewswire
06:30AM  MannKind and One Drop Partner to Launch the A-One Clinical Trial PR Newswire
Aug-04-17 02:41PM  How Bad Will MannKind Corporation's Q2 Results Look? Motley Fool
Jul-25-17 09:00AM  MannKind Corporation to Hold 2017 Second Quarter Financial Results Conference Call on August 7, 2017 GlobeNewswire
Jul-17-17 09:00AM  Steven Binder Joins MannKind as Chief Financial Officer GlobeNewswire +5.47%
Jul-14-17 08:20AM  Today's Research Reports on Stocks to Watch: Mannkind Corporation and AstraZeneca Accesswire
Jul-13-17 08:51AM  Options Traders Expect Huge Moves in MannKind (MNKD) Stock Zacks +12.82%
Jul-12-17 09:00AM  Patrick McCauley Joins MannKind as Chief Commercial Officer GlobeNewswire
Jun-29-17 09:26AM  MannKind Renegotiates Near-Term Maturities with Deerfield GlobeNewswire -6.45%
09:00AM  MannKind Draws Remaining Funds under Mann Group Loan Arrangement GlobeNewswire
Jun-28-17 09:00AM  MannKind Draws Remaining Funds under Mann Group Loan Arrangement GlobeNewswire
Jun-16-17 08:47AM  Is the Options Market Predicting a Spike in MannKind (MNKD) Stock? Zacks
Jun-09-17 08:24AM  3 Surging Penny Stocks You'll Want Nothing to Do With Motley Fool
Jun-05-17 09:00AM  MannKind Engages Locust Walk to Explore Strategic Options for MannKinds Non-insulin Technosphere-based Pipeline Candidates GlobeNewswire
May-31-17 06:00PM  MannKind and Biomm Enter Into Distribution Agreement for Afrezza in Brazil GlobeNewswire -7.88%
May-30-17 09:00AM  MannKind Provides Update on Senior Management GlobeNewswire +8.55%
08:35AM  MannKind Corporation (MNKD) Catches Eye: Stock Jumps 7% Zacks
May-25-17 09:50AM  Short Sellers Raise the Stakes in Major Biotechs 24/7 Wall St. +10.94%
May-17-17 03:08AM  Edited Transcript of MNKD earnings conference call or presentation 10-May-17 9:00pm GMT Thomson Reuters StreetEvents -9.84%
May-11-17 08:41PM  Edited Transcript of MNKD earnings conference call or presentation 10-May-17 9:00pm GMT Thomson Reuters StreetEvents -20.31%
04:09PM  Here's Why MannKind Corporation Stock Is Tanking Today Motley Fool
08:46AM  Implied Volatility Surging for MannKind Corporation (MNKD) Stock Options Zacks
08:00AM  Today's Research Reports on Stocks to Watch: MannKind and Neuralstem Accesswire
May-10-17 04:27PM  MannKind reports 1Q loss Associated Press +42.86%
04:05PM  MannKind Corporation Reports 2017 First Quarter Financial Results GlobeNewswire
10:30AM  Investor Network: MannKind Corporation to Host Earnings Call Accesswire
May-09-17 08:00AM  Today's on Research Reports on Biotech Stocks to Watch: TherapeuticsMD and MannKind Accesswire +10.89%
May-08-17 01:40PM  MannKind Jumps After Amazon Prime Takes on One Drop 24/7 Wall St. +26.69%
May-04-17 08:00AM  MannKind and One Drop to collaborate on delivering better health outcomes for people with diabetes GlobeNewswire
Apr-28-17 09:00AM  MannKind Corporation to Hold 2017 First Quarter Financial Results Conference Call on May 10, 2017 GlobeNewswire
Apr-20-17 07:30AM  Today's Research Reports on Biotech Stocks to Watch: Soligenix and MannKind Accesswire
Apr-10-17 04:22PM  Is MannKind Corporation Getting Ready to Sell? Motley Fool -5.26%
Apr-06-17 08:09AM  Sometimes Your Smartest Investing Move Is to Remain on the Sidelines Motley Fool
Apr-03-17 09:30AM  Conatus Pharmaceuticals and MannKind Look Forward to Promoting Their Brand Accesswire -6.76%
Mar-31-17 08:05AM  3 Companies That Might Not Live to See 2020 Motley Fool
Mar-27-17 10:30AM  Short Interest Pulls Back in Major Biotechs
Mar-23-17 01:04PM  MANNKIND CORP Financials
Mar-22-17 09:23AM  Billionaires' Worst Healthcare Stock Picks for 2017 (So Far) Motley Fool
Mar-21-17 04:23PM  Could MannKind Corporation's Marketing Blitz Pay Off? Motley Fool -5.91%
Mar-20-17 09:50AM  Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now 24/7 Wall St.
Mar-17-17 04:34PM  MANNKIND CORP Files SEC form 8-K, Other Events +7.25%
02:44PM  Edited Transcript of MNKD earnings conference call or presentation 16-Mar-17 9:00pm GMT Thomson Reuters StreetEvents
Mar-16-17 04:38PM  MannKind posts 4Q profit Associated Press
04:17PM  MANNKIND CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  MannKind Corporation Reports 2016 Fourth Quarter and Full Year Financial Results GlobeNewswire
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes diseases in the United States. Its approved product is Afrezza, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. The company was founded in 1991 and is headquartered in Westlake Village, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KRESA KENTDirectorOct 13Buy6.00166,600999,600237,589Oct 13 05:03 PM
Urbanski Raymond W.Corp VP, CMOAug 10Sale1.152963402,924Aug 11 06:17 PM
Alinaya Rosabel RealicaSVP, Investor RelationsJun 30Buy1.232,0002,46030,091Aug 23 07:10 PM
PFEFFER MATTHEW JDirectorJun 30Buy1.232,0002,46082,617Aug 23 07:07 PM
PFEFFER MATTHEW JCEO, CFO, DirectorJan 03Buy0.544,5402,452403,085Jan 04 01:21 PM
Alinaya Rosabel RealicaSVP, Prin Acctg OfficerJan 03Buy0.549,0434,883140,456Jan 04 01:20 PM